Emergence, Mechanism of Action, Clinical Applications and Challenges of Nanomedicine for Tumor Therapy
Journal Title: Diseases & Research - Year 2022, Vol 2, Issue 2
Abstract
With the increase in cancer cases globally, researchers have tried various methods to treat cancer. The study of nanomedicine, a novel drug form, has gained popularity in the medical community. Nanomedicine is a significant component of both nanotechnology and medical technology, and it has attracted the attention of both industry and academia worldwide. Compared with traditional chemotherapy drugs, nanomedicine is great application potential due to its advantages of enhanced drug solubility, high adsorption and biological activity, reduced toxicity, and reduced drug resistance. The drugs used to treat cancer, the idea, and purpose of nanomedicine, its use in clinical settings, and its difficulties are all covered in this article. Numerous mechanisms of nanomedicine therapy have been reported, although it is not yet widely used. In the future, combining nanoparticles with chemotherapeutic agents may be one of the most effective ways to treat cancer.
Authors and Affiliations
Yihang Chen, Jiajun Yu, Zhijie Wang, Juan Li
Keywords
Related Articles
- EP ID EP740153
- DOI 10.54457/DR.202202005
- Views 21
- Downloads 0
Interferons in Colorectal Cancer Pathogenesis and Therapy
As key modulators of the immune response, interferons play critical roles following infection and during the pathogenesis of cancer. The idea that these cytokines might be developed as new therapies emerged soon after th...
Plasma Exchange to Treat Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome after Anti-CD19 Chimeric Antigen Receptor-T Cell Infusion: A Case Report
Adoptive cell immunotherapy with chimeric antigen receptor-T (CAR-T) cells has shown remarkable clinical out-comes. However, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICA...
Determination of mRNA Targets of miR-376c within the RNA-Induced Silencing Complex
Background The focus of the present study was to establish an easy combined method based on the MirTrap system together with a mRNA array to efficiently define target mRNAs which can be bound by miR-376 within the RNA-in...
ADAMTS Proteases: Their Multifaceted Role in the Regulation of Cancer Metastasis
Cancer leads to nearly 10 million deaths worldwide per year. The tumour microenvironment (TME) is fundamental for tumour growth and progression. A key component of the TME, the extracellular matrix (ECM) has recently bec...
Primary Extramedullary Plasmacytoma of the Kidney: A Case Report and Literature Review
Extramedullary plasmacytomas (EMPs) usually occur in the upper respiratory tract, the occurrence in the kidney is extremely rare. The present study reported a case of primary renal plasmacytoma in a 46-year-old male pati...